)
Jorge Santiago-Ortiz
Senior Director CMC,
Apertura Gene Therapy
Sessions
-
03-Sep-2025Theatre 1Spotlight: Advancing CNS Gene Therapies with Manufacturable AAV Capsids and an FDA-Integrated Regulatory Approach
-
03-Sep-2025Theatre 2Panel: From discovery to development – Creating realistic CGT timelines
-
03-Sep-2025Theatre 1Panel: Bridging the characterisation & analytics gap in CGT